(PDF) Cambridge, UK – The Open PHACTS Foundation is proud to announce the official public release of SureChEMBL data in the Open PHACTS Discovery Platform. This marks the first time that SureChEMBL data has been made available to query programmatically via an API.
IMI 2 Open Info Day, Brussels, Belgium Christine Chichester (Swiss Institute of Bioinformatics) represented Open PHACTS.
The recently established Open PHACTS Foundation is part of a proposal for IMI’s 9th Call: WEBAE – Leveraging Emerging Technology for Pharmacovigilance.
The Open PHACTS Foundation is part of a proposal for IMI’s 9th Call – Leveraging Emerging Technology for Pharmacovigilance.
Managing Knowledge about Tissues (Brussels, Belgium)
Semantic Interoperability meeting for the IMI project EHR4CR (Paris, France). Paul Groth presented Open PHACTS at this meeting.
We are proud to announce that Open PHACTS has had a very successful interim review meeting last week. The reviewers congratulated the project on our impressive achievements and recommended that we continue as planned. The reviewers as well as IMI were very impressed by the huge progress made in the project since…
Clinical Data Interchange Standards Consortium training, Brussels, Belgium Open PHACTS participated in this event at the IMI office
IMI Stakeholder Forum 2012, Brussels, Belgium Gerhard Ecker (University of Vienna) and Bryn Williams-Jones (Connected Discovery) gave a presentation: The Open Pharmacological Concepts Triple Store
IMI Stakeholder Forum 2012, Brussels, Belgium Bryn Williams-Jones (Connected Discovery), Gerhard Ecker (University of Vienna) View presentation
Solving Bottlenecks in Data Sharing in the Life Sciences (Volendam, the Netherlands) Co-hosted with GEN2PHEN as a project addressing similar issues around data sharing
(PDF) Vienna, Austria – A new consortium of European organisations unite to support next generation drug discovery by providing a single view across data sources, bringing the semantic web to drug discovery. The Open PHACTS consortium, funded by the Innovative Medicines Initiative, will reduce the barriers to drug discovery by applying semantic…